Evaluation of Flapless Dental Implant Placement in Controlled Type 2 Diabetic Patients(A Randomized Controlled Clinical Trial)

Not Applicable

• Conditions: Nutritional, Metabolic, Endocrine; Oral Health

• Registration Number: PACTR202209543461078
• Lead Sponsor: Oral and Maxillofacial Surgery Department Faculty of Dentistry Alexandria University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-27
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Other
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Diabetic patients with glycosylated hemoglobin (HbA1C) levels of less than 7%.
Absence of microvascular complications of diabetes (such as nephropathy, neuropathy, and retinopathy).
The extraction site healed for at least 6 months in the posterior maxillary molar area.
Sufficient bone height and width.
Adequate keratinized gingiva (KG)  (>2 mm).

Exclusion Criteria

Patient with uncontrolled glycemic index (HBA1c > 7 %).
Patients with acute infection or with relevant systemic diseases or local factors which contraindicate implant placement.
patients with parafunctional habits such as bruxism, clenching……etc.
Patients with poor oral hygiene, and heavy smokers.
Symptoms of generalized periodontitis.
bone augmentation procedure before or during implant placement.

Study & Design

• Study Type: Interventional
• Study Design: Not specified